Optain Health has acquired EyePACS, Inc. for an undisclosed amount. EyePACS, Inc. is a clinical services company dedicated to preventing blindness, particularly from diabetic retinopathy, through its telemedicine and digital imaging platform. This acquisition brings EyePACS's specialized capabilities under Optain Health, a company operating in the healthcare technology sector.
EyePACS developed a cost-effective, web-based program that enables medical clinics to perform early detection and screening for diabetic retinopathy directly within primary care settings. Founded in 2001 by Dr. Jorge Cuadros and Dr. Wyatt Tellis, EyePACS aims to address the significant challenge of low patient compliance with traditional eye exams for diabetics. Its end-to-end services facilitate connections between primary care providers and eye care specialists, improving access to critical screenings. The company's solution is currently utilized by over 600 organizations nationwide, demonstrating its established footprint in digital health.
The acquisition is strategically significant for Optain Health, enhancing its portfolio with a proven solution for a widespread public health issue. Integrating EyePACS's established network and specialized telemedicine technology will likely expand Optain Health's reach in preventive care and digital diagnostics. This move is expected to create synergies by leveraging Optain Health's operational capabilities with EyePACS's clinical expertise and robust platform.
Looking ahead, the combined entity aims to accelerate the adoption of accessible diabetic retinopathy screening programs. By integrating their respective strengths, Optain Health and EyePACS are positioned to improve early detection rates, reduce the risk of preventable blindness, and enhance health outcomes for diabetic patients on a broader scale through innovative and sustainable healthcare solutions.